S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:OMIC

Singular Genomics Systems (OMIC) Stock Price, News & Analysis

$0.51
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.51
$0.53
50-Day Range
$0.41
$0.61
52-Week Range
$0.31
$1.32
Volume
56,504 shs
Average Volume
114,069 shs
Market Capitalization
$38.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.68

Singular Genomics Systems MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
31.3% Upside
$0.68 Price Target
Short Interest
Bearish
1.93% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Singular Genomics Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.86 out of 5 stars

Medical Sector

660th out of 938 stocks

Analytical Instruments Industry

21st out of 26 stocks

OMIC stock logo

About Singular Genomics Systems Stock (NASDAQ:OMIC)

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

OMIC Stock Price History

OMIC Stock News Headlines

Singular Genomics Systems (NASDAQ:OMIC) PT Raised to $0.50
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Singular Genomics Sys: Q4 Earnings Insights
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Singular Genomics Systems earnings: here's what to expect
Preview: Singular Genomics Sys's Earnings
Singular Genomics Systems Inc.
Singular Genomics Systems Founder Acquires 4.6% More Stock
Recap: Singular Genomics Sys Q3 Earnings
OMIC Singular Genomics Systems, Inc.
Singular Genomics Systems Inc OMIC
See More Headlines
Receive OMIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
3/28/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OMIC
Fax
N/A
Employees
284
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.68
High Stock Price Target
$0.85
Low Stock Price Target
$0.50
Potential Upside/Downside
+31.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-94,820,000.00
Net Margins
-3,257.30%
Pretax Margin
-3,257.30%

Debt

Sales & Book Value

Annual Sales
$2.91 million
Book Value
$2.44 per share

Miscellaneous

Free Float
57,739,000
Market Cap
$38.01 million
Optionable
Optionable
Beta
1.40
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Andrew Spaventa (Age 39)
    Founder, CEO, President & Chairperson of the Board
    Comp: $685.93k
  • Dr. David L. Barker Ph.D. (Age 82)
    Founder, Member of Scientific Advisory Board & Independent Director
    Comp: $63.75k
  • Dr. Eli N. Glezer Ph.D. (Age 55)
    Founder, Chief Scientific Officer & Chair of Scientific Advisory Board
    Comp: $496.5k
  • Mr. Dalen Meeter (Age 46)
    Chief Financial Officer
    Comp: $434.39k
  • Jyotsna Ghai
    Chief Operating Officer
  • Mr. Jorge Velarde Jr. (Age 57)
    MBA, Senior Vice President of Corporate Development & Strategy
  • Mr. Jeff Bullard
    Head of Sales
  • Mr. Vincent Brancaccio (Age 41)
    Head of Human Resources
  • Mr. Samuel Ropp Ph.D. (Age 50)
    Chief Commercial Officer

OMIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Singular Genomics Systems stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OMIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares.
View OMIC analyst ratings
or view top-rated stocks.

What is Singular Genomics Systems' stock price target for 2024?

2 Wall Street analysts have issued 12-month price targets for Singular Genomics Systems' stock. Their OMIC share price targets range from $0.50 to $0.85. On average, they anticipate the company's share price to reach $0.68 in the next twelve months. This suggests a possible upside of 31.3% from the stock's current price.
View analysts price targets for OMIC
or view top-rated stocks among Wall Street analysts.

How have OMIC shares performed in 2024?

Singular Genomics Systems' stock was trading at $0.4601 on January 1st, 2024. Since then, OMIC stock has increased by 11.8% and is now trading at $0.5142.
View the best growth stocks for 2024 here
.

When is Singular Genomics Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our OMIC earnings forecast
.

How were Singular Genomics Systems' earnings last quarter?

Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its earnings results on Monday, March, 18th. The company reported ($0.34) earnings per share for the quarter. The business earned $1.08 million during the quarter. Singular Genomics Systems had a negative trailing twelve-month return on equity of 45.33% and a negative net margin of 3,257.30%.

What guidance has Singular Genomics Systems issued on next quarter's earnings?

Singular Genomics Systems updated its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.0 million-$1.0 million, compared to the consensus revenue estimate of 590000.000.

When did Singular Genomics Systems IPO?

Singular Genomics Systems (OMIC) raised $178 million in an initial public offering (IPO) on Thursday, May 27th 2021. The company issued 8,500,000 shares at a price of $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank served as the underwriters for the IPO.

Who are Singular Genomics Systems' major shareholders?

Singular Genomics Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include Perceptive Advisors LLC (2.90%), Vanguard Group Inc. (2.55%), Vanguard Group Inc. (2.55%), Weil Company Inc. (0.19%), Bridgeway Capital Management LLC (0.17%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Andrew Spaventa, Eli N Glezer, James E Flynn, Kim P Kamdar, Michael J Pellini and Sheryl L Conley.
View institutional ownership trends
.

How do I buy shares of Singular Genomics Systems?

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OMIC) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners